That was an interesting 30 mins investor conference this morning. Some tough ( obvious) and really good questions asked by shareholders, and pretty below average reply the other end.
In my opinion the Management always struggled to communicate, properly.
While talking about Business risks which the shareholders were said to bear in mind (to make voting decisions) one of the example quoted was “ we don’t know if Covid is going be there in next 2 years.” I was thinking is this for real! The same guy who said a few weeks or maybe months ago pitching “ Covid is not going away for a long time…” Not sure how the narrative could change just like that.
One positive from the call was he feels confident that even without Pfizer deal the company could do well. We know that Einstein!
My take was ResApp is and will be a great product, subject to right steering committee at the helm. There is indeed a risk, but not because of the product itself, but because of the management. I was utterly disappointed with a mediocre responses.
I’m still going to vote NO.
All in my opinion, please Dyor.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report and Appendix 4C
That was an interesting 30 mins investor conference this...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)